Doris Taylor, PhD, FAHA, FACC
, a leading cell therapy and cardiac regeneration scientist, has joined the Texas Heart Institute (THI)
at St. Luke’s Episcopal Hospital
in Houston. Taylor’s research includes cell and gene therapy for treatment of cardiovascular disease; tissue engineering of bioartificial organs and vasculature, cell-based prevention of disease; stem cells and cancer and holistic approaches to using cell therapy for treating chronic disease.
Most recently, Taylor and her team garnered international recognition for work involving whole organ decellularization by showing they were able to remove existing cells from hearts of laboratory animals and even humans leaving a framework to build new organs.
Taylor has been serving as director of the Center for Cardiovascular Repair and Medtronic Bakken Chair in Integrative Biology and Physiology at the University of Minnesota
. Prior to that she was on the faculty as associate professor in cardiology at Duke University Medical Center
BEFORE YOU GO…
… we’d like to ask for your support. More people are reading the Mississippi Business Journal than ever before, but advertising revenues for all conventional media are falling fast. Unlike many, we do not use a pay wall, because we want to continue providing Mississippi’s most comprehensive business news each and every day. But that takes time, money and hard work. We do it because it is important to us … and equally important to you, if you value the flow of trustworthy news and information which have always kept America strong and free for more than 200 years.
If those who read our content will help fund it, we can continue to bring you the very best in news and information. Please consider joining us as a valued member, or if you prefer, make a one-time contribution.
Click for more info